Home / Health / New COVID Variant BA.3.2 Spreads Globally
New COVID Variant BA.3.2 Spreads Globally
26 Mar
Summary
- New BA.3.2 variant has over 70 gene sequence changes.
- Variant shows immune escape characteristics.
- BA.3.2 is genetically distinct from previous lineages.
A new lineage of SARS-CoV-2, identified as BA.3.2, has emerged and is spreading internationally, with detections reported in 23 countries as of February 11, 2026. The Centers for Disease Control and Prevention (CDC) has been monitoring this variant through its Traveler-Based Genomic Surveillance program. The BA.3.2 variant exhibits notable genetic divergence, boasting about 70 to 75 alterations in the gene sequence of its spike protein.
This unique genetic makeup confers immune escape characteristics, suggesting it may partially evade immunity derived from vaccines or previous infections. While this could lead to more frequent infections, experts indicate it does not necessarily imply increased disease severity. The CDC notes that BA.3.2 represents a distinct lineage, separate from the JN.1 variants that have circulated in the United States since January 2024. Preliminary data from November 2025 to January 2026 showed BA.3.2's prevalence rising to approximately 30% of identified cases in Denmark, Germany, and the Netherlands.
Further analysis has identified two sublineages, BA.3.2.1 and BA.3.2.2, highlighting the ongoing evolution of the virus. Researchers emphasize the necessity of continuous genomic surveillance to track the virus's development and assess its public health implications, especially given potential limitations in detection and surveillance capacities in many countries. The variant was first confirmed in the U.S. in June 2025 in an individual traveling from the Netherlands.
